Viatris (VTRS) Cash from Operations Growth (5y) (2024 - 2026)

Viatris (VTRS) Cash from Operations Growth (5y) (2024 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	88.88 Bn	87.01 Bn	-
2	Teva Pharmaceutical Industries	35.92 Bn	32.18 Bn	1.97 Bn
3	Zoetis	32.31 Bn	30.37 Bn	1.62 Bn
4	Takeda Pharmaceutical	27.54 Bn	23.48 Bn	4.39 Bn
5	United Therapeutics	23.07 Bn	20.91 Bn	648.10 Mn
6	RedHill Biopharma	20.53 Bn	20.53 Bn	-
7	Viatris	20.27 Bn	18.47 Bn	1.16 Bn
8	Neurocrine Biosciences	17.92 Bn	16.61 Bn	800.70 Mn
9	Elanco Animal Health	12.61 Bn	12.18 Bn	785.00 Mn
10	Vireo Growth	10.52 Bn	10.37 Bn	59.30 Mn

Download Data